• Search History (Register)
  • MeSH Browser
  • [Clear]
    • Canada

Welcome to the international HTA database


Showing [3283 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Positron emission tomography for epilepsy: clinical effectiveness and guidelines
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Bluetooth-enabled hearing technologies: a review of the clinical and cost-effectiveness
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Varenicline for smoking cessation in patients with psychiatric illness: a review of the risks
2010     Medical Advisory Secretariat (MAS) Clinical utility of vitamin D testing: an evidence-based analysis
2010     Medical Advisory Secretariat (MAS) Clinical utility of serologic testing for celiac disease in Ontario (symptomatic patients)
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Pain scales in acute care settings: a review of the accuracy and reliability
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Prefabricated and custom made foot orthotics: a review of the clinical and cost-effectiveness
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Infliximab for maintenance therapy for treatment of Crohn's disease: a review of the clinical effectiveness and guidelines
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Percutaneous heart valves for valvular heart disease: an updated review of the clinical and cost-effectiveness and guidelines
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Albumin versus synthetic plasma volume expanders: a review of the clinical and cost-effectiveness and guidelines for use
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Transcatheter aortic valve implantation: a critical appraisal of a health technology assessment and comparison with a rapid review
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Cognitive behavioural therapy for insomnia in adults: a review of the clinical effectiveness
2010     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Weighted blankets and vests: safety, efficacy and issues related to their use in different intervention settings]
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Remote ischemic conditioning: a review of the clinical effectiveness
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening programs for asymptomatic unruptured intracranial aneurysms: review of clinical effectiveness, cost-effectiveness, and evidence-based guidelines
2010     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Robot Assisted Radical Prostatectomy (RARP)]
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Positive versus negative needleless connectors for central venous lines and peripheral lines: a review of the clinical effectiveness and guidelines
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Use of bupropion in patients with depression and the associated risk of seizures: safety
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Fluconazole and pharmaceuticals without inactive ingredients for autism: a review of the clinical effectiveness
2010     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Is there a place for home oxygen therapy in the management of obstructive sleep apnea?]
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Gabapentin tablets versus capsules: a review of the evidence regarding appropriate use
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Eden alternative and green house concept of care: review of clinical effectiveness, cost-effectiveness, and guidelines
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Bifocal lenses under +0.50 diopter: a review of the clinical effectiveness and guidelines
2010     Medical Advisory Secretariat (MAS) KRAS testing for anti-EGFR therapy in advanced colorectal cancer : an evidence-based and economic analysis
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Pre-operative screening and post-operative monitoring in adult patients with obstructive sleep apnea: clinical effectiveness and guidelines
2010     Medical Advisory Secretariat (MAS) Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer : an evidence-based and economic analysis
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Sternal talon for cardiac surgery patients: a review of the clinical effectiveness and guidelines
2010     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Protein-sparing modified fast diet: efficacity, safety and clinical use - literature review]
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Tinnitus retraining therapy: a review of the clinical effectiveness
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Pre-hospital phlebotomy for patients with urgent conditions: a review of the clinical effectiveness and guidelines
2010     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [External evaluation of cancer care organization and delivery: review of experiences relevant to the cancer team evaluation and designation process in Québec]
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Laser refractive surgery in children: a review of the clinical effectiveness and guidelines
2010     Institute of Health Economics (IHE) Sexual exploitation of children and youth over the internet: a rapid review of the scientific literature
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Laparoscopic sleeve gastrectomy: a review of the clinical benefits and harms
2010     Institute of Health Economics (IHE) Treatment for convicted adult male sex offenders
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Filtered needles for withdrawing medication from glass ampoules: a review of the cost-effectiveness and incidence of complications
2010     Institute of Health Economics (IHE) Means restriction for suicide prevention
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Periodontal regenerative procedures for patients with periodontal disease: a review of clinical effectiveness
2010     Institute of Health Economics (IHE) Telehealth in substance abuse and addiction: review of the literature on smoking, alcohol, drug abuse and gambling
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Completely-in-the-canal and bone anchored hearing aids: a review of the clinical effectiveness and cost-effectiveness
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Critical incident stress debriefing for first responders: a review of the clinical benefit and harm
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Cognitive behavioural therapy for patients with addictions: a review of the clinical and cost-effectiveness
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Atypical antipsychotics for the treatment of schizophrenia: a review of combination therapy and high-dosing strategies
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Tramadol compared with opioids for pain: a review of addiction potential
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Percutaneous heart valve replacement for valvular heart disease: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Cognitive behavioural therapy for post traumatic stress disorder: a review of the clinical and cost-effectiveness
2010     Medical Advisory Secretariat (MAS) Extracorporeal lung support technologies - bridge to recovery and bridge to lung transplantation in adult patients: an evidence-based analysis
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Rituximab for non-hodgkin's lymphoma: a review of the clinical and cost- effectiveness and guidelines
2010     Medical Advisory Secretariat (MAS) Solid organ transplantation for End Stage Organ Failure (ESOF) in persons with HIV
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Use of antipsychotics and/or benzodiazepines as rapid tranquilization in inpatients of mental facilities and emergency departments: a review of the clinical effectiveness and guidelines
2010     Medical Advisory Secretariat (MAS) Endovascular laser treatment for varicose veins
2010     Medical Advisory Secretariat (MAS) CT and MRI scans in the evaluation of chronic headaches
2010     Medical Advisory Secretariat (MAS) Cancer screening with digital mammography for women at average risk of breast cancer or MRI for women at high risk
2010     Medical Advisory Secretariat (MAS) Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analaysis
2010     Technology Assessment at SickKids (TASK) Health technology assessment of thiopurine methyltransferase testing for guiding 6-mercaptopurine doses in pediatric patients with acute lymphoblastic leukemia
2010     Technology Assessment at SickKids (TASK) The use of biologic response modifiers in polyarticular-course juvenile idiopathic arthritis
2010     Medical Advisory Secretariat (MAS) The relative cost-effectiveness of five non-invasive cardiac imaging technologies for diagnosing coronary artery disease in Ontario
2010     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Population ultrasound screening for abdominal aortic aneurysms]
2010     Institute of Health Economics (IHE) Evidence on the effectiveness of telerehabilitation applications
2010     Medical Advisory Secretariat (MAS) Use of contrast agents with echocardiography in patients with suboptimal echocardiography
2010     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Cost-benefits evaluation of prevention and control of nosocomial MRSA infections]
2010     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Proton therapy]
2010     Medical Advisory Secretariat (MAS) Negative pressure wound therapy: an evidence update
2010     Institute for Clinical Evaluative Sciences (ICES) Ontario Burden of Infectious Disease Study (ONBOIDS)
2010     Institute for Clinical Evaluative Sciences (ICES) Aging in Ontario: an ICES chartbook of health service use by older adults
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Clopidogrel versus other antiplatelet agents for secondary prevention of vascular events in adults with acute coronary syndrome or peripheral vascular disease: clinical and cost-effectiveness analyses
2010     Institute for Clinical Evaluative Sciences (ICES) How many Canadians will be diagnosed with diabetes between 2007 and 2017? Assessing population risk
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Non-emergency telecardiology consultation services: rapid review of clinical and cost outcomes
2010     Institute for Clinical Evaluative Sciences (ICES) Ontario Stroke Evaluation Report 2010: Technical Report.
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Teledermatology services: rapid review of diagnostic, clinical management, and economic outcomes
2010     Institute for Clinical Evaluative Sciences (ICES) Development of a consensus on evidence-based quality of care indicators for Canadian emergency departments
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Draft report: robot-assisted surgery versus open surgery and laparoscopic surgery: clinical and cost- effectiveness analyses
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Ablation procedures for rhythm control in patients with atrial fibrillation: clinical and cost-effectiveness analyses
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Policy guidance on hip protectors in long-term care
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Triple therapy for moderate-to-severe chronic obstructive pulmonary disease
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Clopidogrel compared with other antiplatelet agents for secondary prevention of vascular events in adults undergoing percutaneous coronary intervention: clinical and cost-effectiveness analyses
2010     Technology Assessment Unit of the McGill University Health Centre (MUHC) Efficacy and cost-effectiveness of a gentamicin-loaded collagen sponge as an adjuvant antibiotic prophylaxis for colorectal surgery
2010     Technology Assessment Unit of the McGill University Health Centre (MUHC) Efficacy, safety and cost of ultrafiltration for the management of acute decompensated heart failure
2010     Technology Assessment Unit of the McGill University Health Centre (MUHC) Argon beam coagulation in orthopaedic, urological and thoracic surgery at the MUHC: a brief report
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Biologic response modifier agents for adults with rheumatoid arthritis
2010     Technology Assessment Unit of the McGill University Health Centre (MUHC) Negative Pressure Wound Therapy (NPWT) (Update of Report 19)
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Third-line therapy for patients with type 2 diabetes inadequately controlled with metformin and a sulfonylurea
2010     Medical Advisory Secretariat (MAS) Non-invasive cardiac imaging technologies for the diagnosis of coronary artery disease
2010     Medical Advisory Secretariat (MAS) Single photon emission computed tomography for the diagnosis of coronary artery disease
2010     Medical Advisory Secretariat (MAS) Stress echocardiography for the diagnosis of coronary artery disease
2010     Medical Advisory Secretariat (MAS) Stress echocardiography with contrast for the diagnosis of coronary artery disease
2010     Medical Advisory Secretariat (MAS) 64-slice computed tomographic angiography for the diagnosis of intermediate risk coronary artery disease
2010     Medical Advisory Secretariat (MAS) Cardiac magnetic resonance imaging for the diagnosis of coronary artery disease
2010     Medical Advisory Secretariat (MAS) Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis
2010     Medical Advisory Secretariat (MAS) Percutaneous vertebroplasty for treatment of painful osteoporotic vertebral compression fractures
2010     Medical Advisory Secretariat (MAS) Negative pressure wound therapy: an evidence update
2010     Medical Advisory Secretariat (MAS) Epidermal Growth Factor Receptor Mutation (EGFR) testing for prediction of response to EGFR-targeting Tyrosine Kinase Inhibitor (TKI) drugs in patients with advanced non-small-cell lung cancer : an evidence-based and economic analysis
2010     Medical Advisory Secretariat (MAS) Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis
2010     Medical Advisory Secretariat (MAS) Non-invasive cardiac imaging technologies for the assessment of myocardial viability
2010     Medical Advisory Secretariat (MAS) Neuroimaging for the evaluation of chronic headaches : an evidence-based analysis
2010     Medical Advisory Secretariat (MAS) Balloon kyphoplasty for treatment of painful osteoporotic vertebral compression fractures : an evidence update
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Positron emission tomography for cardiovascular disease: a review of the clinical effectiveness
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Positron emission tomography (PET) in oncology: a systematic review of clinical effectiveness and indications for use
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Second-line therapy for patients with diabetes inadequately controlled on metformin: a systematic review and cost-effectiveness analysis
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Recombinant activated factor VII for prevention of bleeding unrelated to hemophilia: clinical and economic systematic review